The purpose of Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19 Clinical Trial Not Allowed) (RFA-AI-20-001) is to solicit applications to establish multidisciplinary research programs focused on improving our understanding of bacterial and host factors important for drug resistance and infection by bacterial pathogens for which antibiotic resistance is a known public health concern to inform new ways to prevent, diagnose, and treat antibacterial-resistant infections.
Unifying themes can include computational approaches.
Letters of Intent are due April 8, 2020.
Applications are due May 8, 2020 by 5:00PM local time of applicant organization.
Get more information here.
Scientific/Research Contact: Nancy Lewis Ernst, PhD, NIAID
Peer Review Contact: Annie Walker-Abbey, PhD, NIAID
Financial/Grants Management Contact: Regina Kitsoulis, NIAID